Cancer Clinical Trials | Maryland | Adventist HealthCare - Adventist HealthCare

Clinical Trials

Browse cancer clinical trials at Adventist HealthCare.

What’s a Clinical Trial?

A clinical trial is a research study that tests a new medical device, medication or other therapy before it’s widely available. The study is done to see if the treatment works safely. The results of the study help researchers learn better ways to prevent, detect or treat cancer.

Should I Participate in a Clinical Trial?

When you take part in a clinical trial, your health may improve from the treatment. But it may not, and you may have side effects. Talk to your doctor about the potential risks and benefits.

Expert Researchers

At Adventist HealthCare, your clinical trial will be led by a team of specialists made up of doctors, clinical research nurses, research associates and assistants who do more than 65 cancer studies each year.

Search Cancer Clinical Trials

Showing 1-10 of 11

Sorted By:

  • Doxorubicin Hydrochloride/Cyclophosphamide

    Study of how doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel work in treating patients with triple negative breast cancer.

  • IMpassion130

    Study evaluates the efficacy, safety, and pharmacokinetics of atezolizumab administered with nab-paclitaxel compared with placebo.

  • NRG-BR003

    Randomized phase III trial to study how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer.

  • PALLAS

    Study evaluating the addition of 2 years of palbocicilib to standard adjuvant endocrine therapy for patients with HR+/HER2 early breast cancer (EBC).

  • PATRICIA/ML29366

    Study will examine the safety and efficacy of pertuzumab in combination with high-dose trastuzumab in adult participants with HER2-positive MBC with CNS metastases and disease progression in the brain following radiotherapy.

  • SANDPIPER

    International, multicenter, randomized, double-blinded, placebo-controlled study designed to compare the efficacy and safety of taselisib + fulvestrant with that of placebo + fulvestrant in postmenopausal women.

  • STAR Cape+BKM120

    Study to determine the safety and effectiveness of BKM120 plus capecitabine in breast cancer patients with brain metastases.

  • SystHERs Registry

    This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).

  • USO 14052

    Phase 2, open-label, single arm, multicenter, 2-stage study of eribulin mesylate administered biweekly at 1.4 mg/m2 intravenously for the treatment of participants with HER2-negative metastatic breast cancer previously treated with 2 to 5 chemotherapy regimens.

  • USOR 13033

    A clinical research study to learn if the study drug, alisertib, in combination with chemotherapy (paclitaxel), can shrink or slow tumor growth in women.

Page InfoPage
Page of 2, showing trials 1-10 of 11

Talk to a Cancer Navigator

Request a free consultation today to learn about our services.

Request a Consult

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.